Product
Interferon
4 clinical trials
11 indications
Indication
Breast CancerIndication
Breast NeoplasmIndication
Breast Cancer MetastaticIndication
Lymphomatoid GranulomatosisIndication
GranulomatosisIndication
LymphomatoidIndication
Non-Hodgkin's LymphomaIndication
lymphoproliferative disorderIndication
Interstitial CystitisIndication
Chronic Hepatitis BIndication
COVID-19Clinical trial
A Phase I/II Study of the SV-BR-1-GM Regimen in Metastatic or Locally Recurrent Breast Cancer Patients in Combination With RetifanlimabStatus: , Estimated PCD: 2024-06-30
Clinical trial
Treatment and Natural History Study of Lymphomatoid GranulomatosisStatus: Active (not recruiting), Estimated PCD: 2030-02-01
Clinical trial
Assessing the Effectiveness and Safety of Interferon Bladder Infusion for the Treatment of Interstitial Cystitis: a Randomized, Double-blind, Placebo-controlled StudyStatus: Not yet recruiting, Estimated PCD: 2024-10-15
Clinical trial
The Observational Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral TherapyStatus: Recruiting, Estimated PCD: 2023-12-01